P50 CA83639/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2000	2
2001	3
2002	2
2003	2
2004	6
2005	10
2006	8
2007	5
2008	4
2009	8
2010	5
2011	12
2012	7
2013	4
2014	3
2015	5
2016	4
2024	0

1

Src family kinases and paclitaxel sensitivity.

Le XF, Bast RC Jr. Le XF, et al. Cancer Biol Ther. 2011 Aug 15;12(4):260-9. doi: 10.4161/cbt.12.4.16430. Epub 2011 Aug 15. Cancer Biol Ther. 2011. PMID: 21646863 Free PMC article. Review.

2

Biomarkers for ovarian cancer: new technologies and targets to address persistently unmet needs.

Bast RC Jr. Bast RC Jr. Cancer Biomark. 2010-2011;8(4-5):161-6. doi: 10.3233/CBM-2011-0209. Cancer Biomark. 2010. PMID: 22045350 No abstract available.

3

Molecular approaches to personalizing management of ovarian cancer.

Bast RC Jr. Bast RC Jr. Ann Oncol. 2011 Dec;22 Suppl 8(Suppl 8):viii5-viii15. doi: 10.1093/annonc/mdr516. Ann Oncol. 2011. PMID: 22180401 Free PMC article. Review.

4

LIG4 mediates Wnt signalling-induced radioresistance.

Jun S, Jung YS, Suh HN, Wang W, Kim MJ, Oh YS, Lien EM, Shen X, Matsumoto Y, McCrea PD, Li L, Chen J, Park JI. Jun S, et al. Nat Commun. 2016 Mar 24;7:10994. doi: 10.1038/ncomms10994. Nat Commun. 2016. PMID: 27009971 Free PMC article.

5

Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy.

Romero I, Bast RC Jr. Romero I, et al. Endocrinology. 2012 Apr;153(4):1593-602. doi: 10.1210/en.2011-2123. Epub 2012 Mar 13. Endocrinology. 2012. PMID: 22416079 Free PMC article. Review.

6

Current state of biomarker development for clinical application in epithelial ovarian cancer.

Moore RG, MacLaughlan S, Bast RC Jr. Moore RG, et al. Gynecol Oncol. 2010 Feb;116(2):240-5. doi: 10.1016/j.ygyno.2009.09.041. Epub 2009 Oct 31. Gynecol Oncol. 2010. PMID: 19879639 Free PMC article. Review.

7

Emerging role of RAB GTPases in cancer and human disease.

Cheng KW, Lahad JP, Gray JW, Mills GB. Cheng KW, et al. Cancer Res. 2005 Apr 1;65(7):2516-9. doi: 10.1158/0008-5472.CAN-05-0573. Cancer Res. 2005. PMID: 15805241 Review.

8

Rethinking ovarian cancer: recommendations for improving outcomes.

Vaughan S, Coward JI, Bast RC Jr, Berchuck A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R, Etemadmoghadam D, Friedlander M, Gabra H, Kaye SB, Lord CJ, Lengyel E, Levine DA, McNeish IA, Menon U, Mills GB, Nephew KP, Oza AM, Sood AK, Stronach EA, Walczak H, Bowtell DD, Balkwill FR. Vaughan S, et al. Nat Rev Cancer. 2011 Sep 23;11(10):719-25. doi: 10.1038/nrc3144. Nat Rev Cancer. 2011. PMID: 21941283 Free PMC article.

9

Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.

Chen MY, Liao WS, Lu Z, Bornmann WG, Hennessey V, Washington MN, Rosner GL, Yu Y, Ahmed AA, Bast RC Jr. Chen MY, et al. Cancer. 2011 Oct 1;117(19):4424-38. doi: 10.1002/cncr.26073. Cancer. 2011. PMID: 21491416 Free PMC article.

10

The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck.

Mandal M, Younes M, Swan EA, Jasser SA, Doan D, Yigitbasi O, McMurphey A, Ludwick J, El-Naggar AK, Bucana C, Mills GB, Myers JN. Mandal M, et al. Oral Oncol. 2006 Apr;42(4):430-9. doi: 10.1016/j.oraloncology.2005.09.011. Epub 2006 Jan 27. Oral Oncol. 2006. PMID: 16442835 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Results by year